...
首页> 外文期刊>Journal of Cancer Research and Therapeutics >Exploring new potentials and generating hypothesis for management of locally advanced head neck cancer: Analysis of pooled data from two phase II trials
【24h】

Exploring new potentials and generating hypothesis for management of locally advanced head neck cancer: Analysis of pooled data from two phase II trials

机译:探索新的潜力并为局部晚期头颈癌的治疗产生假设:两项两项II期试验的汇总数据分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: To study the long term results of two phase II concurrent chemoradiotherapy protocols and conduct pooled data analysis with special emphasis on nodal density. Materials and Methods: In the period from April 2001 to May 2003, phase II Mitomycin C (MMC) and late chemo-intensification (LCI) protocols were started in the same institute, enrolling 69 and 74 patients respectively. Long term results for these individual trials are reported along with pooled data analysis. Results: Median follow-up time for whole group, MMC protocol and LCI protocol was 43.8 months (SD619.8), 55 months (SD 618.5) and 47.5 months (SD 620.9) respectively. LRFS, DFS and OS at five years for whole group was 59.4, 43.5 and 47.1% respectively, for MMC protocol was 59.9, 45.5 and 49.5% respectively and for LCI, protocol was 53.6%, 41.5% and 44.4% respectively. Subgroup analysis revealed that MMC protocol was more effective than LCI protocol in terms of DFS and OS in patients with hypo dense nodes while opposite was true for Isodense nodes. Multivariate analysis revealed nodal density as an independent variable that had an impact on treatment outcome. Risk of death in patients with hypo dense nodes was 2.91 times that of Isodense nodes. Conclusions: Innovative and pragmatic approach is required to address locally advanced head neck cancer. Long term results for MMC and LCI protocols are encouraging. Integrating the basic concepts of these protocols may help develop new protocols, which will facilitate the search for the optimal solution.
机译:背景:研究两种同时进行的第二期放化疗方案的长期结果,并进行汇总数据分析,重点是节点密度。材料与方法:2001年4月至2003年5月,在同一所机构开始进行II期丝裂霉素C(MMC)和晚期化学强化(LCI)方案,分别招募69例和74例患者。这些单独试验的长期结果与汇总数据分析一起报告。结果:全组,MMC方案和LCI方案的中位随访时间分别为43.8个月(SD619.8),55个月(SD 618.5)和47.5个月(SD 620.9)。整个组五年的LRFS,DFS和OS分别为59.4、43.5和47.1%,MMC协议分别为59.9、45.5和49.5%,LCI协议分别为53.6%,41.5%和44.4%。亚组分析显示,对于低密度结节患者,MMC协议在DFS和OS方面比LCI协议更有效,而Isodense节点则相反。多变量分析表明,淋巴结密度是一个独立变量,对治疗结果有影响。低密度淋巴结患者的死亡风险是伊索登塞淋巴结的2.91倍。结论:需要创新和务实的方法来解决局部晚期头颈癌。 MMC和LCI协议的长期结果令人鼓舞。集成这些协议的基本概念可能有助于开发新协议,这将有助于寻找最佳解决方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号